Page last updated: 2024-12-05

1-pentene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Pentene is an alkene with the formula CH3CH2CH2CH=CH2. It is a colorless gas at room temperature and is a common industrial chemical. 1-Pentene is produced by the cracking of petroleum and is used as a monomer in the production of polymers, such as polyethylene. It is also used as a fuel and as a solvent. 1-Pentene is a flammable and reactive compound and should be handled with care. It is also a significant component of gasoline and can be used in the production of high-octane gasoline.'

1-pentene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8004
CHEMBL ID295337
MeSH IDM0365744

Synonyms (52)

Synonym
25377-72-4
propylethylene
hsdb 1086
einecs 203-694-5
alpha-amylene
alpha-n-amylene
1-pentylene
.alpha.-n-amylene
109-67-1
inchi=1/c5h10/c1-3-5-4-2/h3h,1,4-5h2,2h
1-pentene
pent-1-ene
NCGC00090824-01
1-n-pentene
1-pentene, 98%
pentene
1-pentene, >=98.5% (gc)
CHEMBL295337
P0316
1-amylene
NCGC00090824-02
AKOS009157547
alp8m0lu81 ,
unii-alp8m0lu81
ec 203-694-5
cas-109-67-1
dtxsid7025849 ,
dtxcid905849
tox21_200280
NCGC00257834-01
68814-91-5
alkenes, c5-9 alpha-
einecs 272-344-1
einecs 271-255-5
FT-0608205
1-pentene [hsdb]
pentene, 1-n-
1-pentene [mi]
pentene-1
alkenes, c5-9 .alpha.-
1-pentene 95
1-c5h10
FD10489
mfcd00003567
J-002314
1-pentene, analytical standard
Q6018906
pentaene
pent-4-ene-1
25587-78-4
?1-pentene
EN300-119395
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
interleukin 8Homo sapiens (human)Potency74.97800.047349.480674.9780AID651758
thyroid stimulating hormone receptorHomo sapiens (human)Potency3.16230.001318.074339.8107AID926; AID938
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency78.44820.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency56.03180.000817.505159.3239AID1159527
aryl hydrocarbon receptorHomo sapiens (human)Potency22.38720.000723.06741,258.9301AID651777
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency66.82420.000627.21521,122.0200AID651741
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID212400Toxicity determined using Tadpole Narcosis Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (18.18)18.2507
2000's3 (27.27)29.6817
2010's6 (54.55)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 62.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index62.68 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index98.77 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (62.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]